Landscapes / Companies
Teligene US not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
Drugs
3
in active trials
Trials
4 active
4 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Phase 2 | Dec 2027Phase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Non-small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2027Phase 2 trial completes | |||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2028Phase 2 trial completes | |||
| Next date | Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Colorectal Cancer Metastatic, Advanced Colorectal Cancer | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021